
Irisin, a hormone released during exercise, appears to directly shield neurons from damage in a mouse model of multiple sclerosis.
Photo Credit: Anupam Mahapatra
Scientific Frontline: Extended "At a Glance" Summary: Irisin and Neuroprotection in Multiple Sclerosis
The Core Concept: Irisin is a muscle-derived hormone released during aerobic exercise that directly shields neurons from damage and reduces clinical disability in preclinical models of multiple sclerosis (MS).
Key Distinction/Mechanism: Unlike current MS therapies that reduce inflammation by suppressing the immune system, irisin acts directly on central nervous system neurons to halt neurodegeneration without altering peripheral immune cell activity.
Major Frameworks/Components:
- Genetic Knockout Models: Deleting the gene responsible for encoding irisin in preclinical models completely erased the neuroprotective benefits typically conferred by exercise.
- Gene Therapy Recovery: Artificially elevating blood levels of irisin via experimental gene therapy rescued neurons and restored a neuroprotective gene expression program.
- Targeted CNS Protection: Irisin specifically reduced synapse and neuronal loss in critical anatomical regions, including the spinal cord, hippocampus, and retina.














.jpg)



